Literature DB >> 19475639

Discovery of selective luteinizing hormone receptor agonists using the bivalent ligand method.

Kimberly M Bonger1, Richard J B H N van den Berg, Annemiek D Knijnenburg, Laura H Heitman, Chris J van Koppen, Cornelis M Timmers, Herman S Overkleeft, Gijsbert A van der Marel.   

Abstract

Two series of dimeric ligands for a G-protein-coupled receptor were prepared that differ by the interconnecting spacer system. Biological evaluation revealed that both dimeric series exhibit unique biological properties relative to their monomeric counterparts.The luteinizing hormone receptor (LHR), the follicle-stimulating hormone receptor (FSHR), and the thyroid-stimulating hormone receptor (TSHR) belong to the glycoprotein hormone receptor (GpHR) family. A prominent feature of all endogenous glycoprotein ligands is that they share an identical alpha subunit and acquire their selectivity from the unique beta subunit. Recent developments in pro-fertility research have led to the discovery of several low-molecular-weight agonists for the luteinizing hormone/choriogonadotropin receptor that bind to the transmembrane (TM) region of the LHR. Interestingly, some of these agonists are also able to activate the FSHR. Several research groups have shown that ligand dimerization presents a powerful tool to increase the subtype selectivity for structurally related G-protein-coupled receptors. In this work, we applied the dimerization strategy to GpHRs and explored the effect on receptors with closely related TM regions. Two series of dimeric ligands were prepared that differ in the interconnecting spacer system. Biological evaluation revealed that both series exhibit unique selectivity properties for the LHR, originating from either decreased potency or a decreased efficacy toward the FSHR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475639     DOI: 10.1002/cmdc.200900058

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  4 in total

1.  Development of Selective LH Receptor Agonists by Heterodimerization with a FSH Receptor Antagonist.

Authors:  Kimberly M Bonger; Sascha Hoogendoorn; Chris J van Koppen; C Marco Timmers; Gijsbert A van der Marel; Herman S Overkleeft
Journal:  ACS Med Chem Lett       Date:  2010-11-08       Impact factor: 4.345

2.  Human TSH receptor ligands as pharmacological probes with potential clinical application.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Expert Rev Endocrinol Metab       Date:  2009-11-01

Review 3.  Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists.

Authors:  Ross C Anderson; Claire L Newton; Robert P Millar
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-23       Impact factor: 5.555

Review 4.  Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors.

Authors:  Selvaraj G Nataraja; Henry N Yu; Stephen S Palmer
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-14       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.